Brian Skorney


Baird Remains Bearish on Cempra Pharmaceuticals (CEMP); Believes Restrictions on Solithromycin Will Render Drug Commercially Unviable

Though the FDA’s Antimicrobial Drugs Advisory Committee voted in a 7-6 vote in favor of approval for Cempra Pharmaceuticals (NASDAQ:CEMP) pipeline drug solithromycin, …

Baird Bullish on Sarepta Therapeutics Inc (SRPT) Amid DMD Franchise Expansion Deal

Tuesday, Sarepta Therapeutics Inc (NASDAQ:SRPT) and Summit Therapeutics PLC (ADR) (NASDAQ:SMMT) announced a deal that will grant Sarepta European commercialization rights for Summit’s …

Baird’s Focus Ideas: Gilead Sciences, Inc. (GILD), Achillion Pharmaceuticals, Inc. (ACHN)

With summer approaching, most of the major brokerage firms are making some changes and additions to their firms top stock ideas. At one of …

Vertex Pharmaceuticals Incorporated’s (VRTX) Pipeline Drug Approved By FDA; Analysts Bullish

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) excited Wall Street on July 2 after the company announced that the U.S.

Analysts Remain Bullish on Gilead Despite Safety Warning

  Gilead Sciences Inc (NASDAQ: GILD) issued a new warning about its hepatitis C drugs after discovering a dangerous interaction with amiodarone, a drug that …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts